20 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
7:03am
product into the ongoing Phase 1 clinical trial
Strong Financial Position $329M includes funds as of August 31, 2023, and $60M from Pfizer deal R&D collaboration
8-K
EX-99.1
hw7h0o
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
rmmh87c7 uq0oxs
26 May 22
Other Events
7:02am
8-K
EX-99.1
j752rrt
26 May 22
Other Events
7:02am
8-K
EX-99.2
mgw 2xb22z
26 May 22
Other Events
7:02am
8-K
EX-99.1
byaiv
10 Jan 22
Other Events
7:11am
10-K
1l5jsel777zmhvt8s
16 Feb 21
Annual report
4:11pm
10-Q
iym2 viqwavc
14 Oct 20
Quarterly report
4:02pm
S-1
EX-10.9
ncegwrlzii747 6t
2 Jul 20
IPO registration
4:04pm
DRS
EX-10.9
7jk 35qif2k
5 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next